毛细管电泳法同时分析茶黄素类和儿茶素类化合物

为了建立一种快速、准确、简便的同时分析茶黄素类和儿茶素类化合物的毛细管电泳方法以满足茶黄素体外氧化制备过程监测和茶多酚酶促氧化动力学研究的需要,研究了毛细管电泳同时分析4种茶黄素类和6种儿茶素类化合物的最佳分析条件,并将建立的方法进行应用评价。结果表明:以含有200 mmol/L H3BO3(pH 7.7)、10 mmol/L KH2PO4、9 mmol/L β-环糊精和27.5%乙腈为电泳介质,在电压25 kV、柱温30 ℃下分离和200 nm波长处检测,可在8 min内将10种待测组分全部分离,且各组分的浓度与峰面积呈良好的线性关系,相关系数r为0.9907～0.9998,检测限为0.39～0.88 μg/mL,各组分的加标回收率为91.5%～113.5%,相对标准偏差小于5%。     

高效液相色谱法测定红茶中的茶黄素

建立了一种用于分析红茶中茶黄素的高效液相色谱法。该方法采用反相C18柱;流动相A为2%醋酸,流动相B为乙腈-乙酸乙酯(体积比为21∶3),梯度洗脱,流速0.8 mL/min;紫外检测波长280 nm;柱温40 ℃;外标法定量。结果表明,所采用的标准曲线有良好的线性关系(r=0.9990~0.9992),加标回收率为96.88%~103.57%,方法的精密度良好(平均RSD<1.5%)。该方法简便、快速、准确,可用于实际样品的测定。     

Anti-Cancer Properties of Theaflavins

Cancer is a disease characterized by aberrant proliferative and apoptotic signaling pathways, leading to uncontrolled proliferation of cancer cells combined with enhanced survival and evasion of cell death. Current treatment strategies are sometimes ineffective in eradicating more aggressive, metastatic forms of cancer, indicating the need to develop novel therapeutics targeting signaling pathways which are essential for cancer progression. Historically, plant-derived compounds have been utilized in the production of pharmaceuticals and chemotherapeutic compounds for the treatment of cancer, including paclitaxel and docetaxel. Theaflavins, phenolic components present in black tea, have demonstrated anti-cancer potential in cell cultures in vitro and in animal studies in vivo. Theaflavins have been shown to inhibit proliferation, survival, and migration of many cancer cellswhile promoting apoptosis. Treatment with theaflavins has been associated with increased levels of cleaved poly (ADP-ribose) polymerase (PARP) and cleaved caspases-3, -7, -8, and -9, all markers of apoptosis, and increased expression of the proapoptotic marker Bcl-2-associated X protein (Bax) and concomitant reduction in the antiapoptotic marker B-cell lymphoma 2 (Bcl-2). Additionally, theaflavin treatment reduced phosphorylated Akt, phosphorylated mechanistic target of rapamycin (mTOR), phosphatidylinositol 3-kinase (PI3K), and c-Myc levels with increased expression of the tumour suppressor p53. This review summarizes the current in vitro and in vivo evidence available investigating the anti-cancer effects of theaflavins across various cancer cell lines and animal models.